Inactive Instrument

Other languages Bio-Path Holdings Inc Nasdaq

Equities

US09057N2018

Other languages

Unlock all the news: Be the first to know and act before the market!

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress	24/05
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting	24/05
Transcript : Bio-Path Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024	15/05
Bio-Path: Q1 Earnings Snapshot	15/05
Bio-Path Holdings Reports First Quarter 2024 Financial Results	15/05
Bio-Path Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024	08/05
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	22/04
Bio-Path Closes $1.2 Million Share Offering	19/04
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-theMarket Under Nasdaq Rules	19/04
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	18/04
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients	18/04
Bio-Path Holdings, Inc. Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1B Clinical Trial of Bp1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients	18/04
Bio-Path Holdings Expands Global Patent Portfolio	15/04
Bio-Path Holdings, Inc. Expands Global Patent Portfolio	15/04
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	05/04
Bio-Path Holdings Provides 2024 Clinical and Operational Update	02/04
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23	28/03
Bio Path : Failure to Satisfy Listing Rule - Form 8-K	14/03
Transcript : Bio-Path Holdings, Inc., Q4 2023 Earnings Call, Mar 08, 2024	08/03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bio-Path Holdings Inc Nasdaq

Equities

US09057N2018

Other languages

Filters